A report is presented on the solubility, absorption, and excretion of a new sulphonamide, 3: 4 -dimethyl -5 -sulphan lamido-isoxazole, formerly known as " Nu 445 " and now called "gantrisin." The authors have used this sulphonamide in the treatment of 300 patients and have not found any evidence of renal damage due to the drug. It is more soluble than sulphadiazine in urine at about pH 6.3, having a solubility of 327 mg. per 100 ml. compared with 13 mg. per 100 ml. for sulphadiazine. The solubility of sulphadiazine only approaches that of gantrisin when the pH is raised to 7 or 8. The free form of gantrisin is more soluble than the acetylated form up to pH 6.6, whereas the opposite is true of sulphadiazine.
Gantrisin was given orally, intramuscularly, and intravenously, the dosage varying from 1 to 2 g. every 4 hours. A maximum total concentration in the blood of 9 to 17 mg. per 100 ml. was obtained, according to the route of administration. The acetylated portion varied between 28% and 35% of the total. Excretion in the urine followed the usual pattern of sulphonamide excretion, the major portion of the dose, 80 (A.C.T.H.) . One of the patients also received 17-hydroxycorticosterone (compound F). Seventeen of the patients had rheumatoid arthritis and 5 rheumatoid arthritis and spondylitis; 8 had acute rheumatic fever; one had disseminated lupus erythematosus; and one psoriasis and psoriatic arthritis. Among the changes produced by the administration of these hormones were increase in body weight, rounding of the facial contours, and the production of acne, hirsuties, keratitis pilaris, and cutaneous striae. Muscular weakness, amenorrhoea, and euphoria were sometimes found. The urinary excretion of corticosteroids rose above the normal level during administration of the hormones, while that of 17-ketosteroids fell rapidly at first, later becoming stabilized or rising again. There was no apparent relation between the effects produced by the hormones on the metabolism and the clinical response of the arthritis. There was an increased excretion of creatine and of uric acid in the urine and the production of a hypochloraemic hypopotassaemic alkalosis. The effect of the hormones on sodium and chloride balance was variable, but there tended to be a retention of both in the early stages and an increased excretion after prolonged administration. A negative nitrogen balance was produced, together with significant increases in urinary calcium and phosphorus excretion, and also an increase in faecal phosphorus. Conspicuous alterations in carbohydrate tolerance were not produced; more striking changes might be expected if the hormone were given to actual or potential diabetics.
Many of the manifestations of Cushing's syndrome were produced by protracted administration of cortisone, and there was evidence that cortisone is capable of depressing the function of the adrenal cortex in man as it does in the rat.
Geoffrey McComas. The salt tolerance test (Soffer et al., J. clin. Invest., 1944, 23, 51) was carried out on 22 normal subjects and on 15 patients with adrenal cortex hyperfunction. In JO patients administration of deoxycortone acetate (DCA) resulted in a diuresis of sodium and chloride. After x-ray treat-ment to the pituitary of one patient in whom there had previously been salt diuresis following DCA administration, salt retention was demonstrated. The blood sodium concentration was measured in 9 patients and was found to be considerably increased in 3 cases, in which the tolerance test showed salt retention, and normal in the others. Only in one out of the six cases in which the blood sodium concentration was normal was salt retention demonstrated.
A. Schweitzer.
Electrophoretic Findings in Myelomatosis.
SOULIER, J. P. (1950) . Sang, 21, 37.
This is a well-documented description of the electrophoretic findings in myelomatosis.
The conclusions are: (1) There is no invariable type of electrophoretic curve in myelomatosis. Four different electrophoretic types have been observed, and in 9 cases the curve was sufficiently characteristic to permit of a diagnosis. (2) There is no relation between the presence or absence of proteinuria and the electrophoretic curve in myelomatosis. In 5 cases, which did not belong to the same electrophoretic type, proteinuria was found. A distinction is made between the presence of thermosoluble protein of Bence-Jones, or globulin of small molecular weight, and non-thermosoluble proteinuria. (3) The authors describe the successful transfusion with saline-washed red cells of 11 patients who were apparently sensitive to some factor(s) in human plasma and who had developed reactions after the transfusion of whole blood. The patients were suffering from chronic haemolytic anaemia (6 cases), leukaemia (3 cases), and myelofibrosis and carcinomatosis (1 case of each). The reactions were characterized chiefly by rigors and fever and often a lack of red cell response, but haemolysis was not proved to be a cause.
The nature of the plasma factor was not determined; the reactions did not seem to be due to the transfusion of iso-antibodies.
In In 44 patients with evidence of nitrogen retention due to renal disease, the severity of anaemia was related to the degree of nitrogen retention. In 80% of patients the bone marrow was hypercellular. A minor degree of hypoplasia of the erythroid tissue was observed only in patients having concentrations of non-protein nitrogen greater than 150 mg. per 100 ml. of plasma. Leucopoiesis and thrombopoiesis were not depressed.
Parahaemophilia (Owren) , a New Type of Haemorrhagic Diathesis. FRANK, E., BILHAN, N., and EKREN, H. (1950) . Acta haematol. Basel, 3, 70.
The authors describe a patient suffering from a haemorrhagic diathesis due to a deficiency of Owren's factor V. Vitamin K had no effect on the prolonged prothrombin time, but the addition in vitro of prothrombin-free plasma or pure factor V restored the prothrombin time to normal. The patient's plasma added to haemophilic plasma corrected the deficiency in the latter, while prothrombin-free plasma from a haemophiliac corrected the defect of the patient. 
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